https://www.thebodypro.com/tag/interviews

Interviews

The Latest

COVID-19 patient care-iStock-1218539192

Can Drugs That Cure Hepatitis C Treat COVID-19? Here’s the State of the Research So Far.

An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.

By Terri Wilder, M.S.W.
Wakefield headshot.

This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect

Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.

By Kenyon Farrow
injectable

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
LaRon Nelson headshot.

COVID-19 (and HIV) Disparities Are About Racism, Not Race. This Nurse Explains How

LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.

By Terri Wilder, M.S.W.
Catherine Hanssens.

Leading With a Public Health Response to COVID-19 in Prisons and Jails

Legal groups provide pathways to reducing coronavirus spread in carceral settings.

By Terri Wilder, M.S.W.
Suraj Madoori, M.P.H., M.S.J., M.A. and Annette Gaudino

Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead

A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.

By Terri Wilder, M.S.W.
Lynne Mofenson

After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?

This researcher has some ideas about what we need to do to address the problem.

By Terri Wilder, M.S.W.
Natalia Linos headshot.

How to End COVID-19 and Other Pandemics With a Human Rights and Health Justice Approach

Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.

By Terri Wilder, M.S.W.
cisgender woman prescription

Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It

Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.

By Terri Wilder, M.S.W.
Gal Mayer.

A Longtime HIV/LGBTQ Doctor Volunteered in a New York City Public Hospital Against COVID-19. Here’s What He Learned.

“It was like you were in the Lifetime movie version of a hospital,” Mayer said.

By Tim Murphy